Report overview
Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology. This report contains market size and forecasts of Flow Cytometry in Oncology in global, including the following market information:
Global Flow Cytometry in Oncology Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Flow Cytometry in Oncology market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Assays and Kits Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Flow Cytometry in Oncology include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation and Miltenyi Biotec B.V. and Co. KG, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Flow Cytometry in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flow Cytometry in Oncology Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Flow Cytometry in Oncology Market Segment Percentages, by Type, 2023 (%)
Assays and Kits
Instruments
Reagents and Consumables
Software
Global Flow Cytometry in Oncology Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Flow Cytometry in Oncology Market Segment Percentages, by Application, 2023 (%)
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
Global Flow Cytometry in Oncology Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Flow Cytometry in Oncology Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flow Cytometry in Oncology revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Flow Cytometry in Oncology revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flow Cytometry in Oncology, market overview.
Chapter 2: Global Flow Cytometry in Oncology market size in revenue.
Chapter 3: Detailed analysis of Flow Cytometry in Oncology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flow Cytometry in Oncology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
